Ownership history in XTX Topco Ltd · 7 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in PTC THERAPEUTICS INC (PTCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 7,410 | -28,577 | -79.4% | 0.02% | $455K | $61.37 |
| 2025 Q1 | ADDED | 35,987 | +22,764 | +172.2% | 0.09% | $1.8M | $50.96 |
| 2024 Q4 | REDUCED | 13,223 | -17,748 | -57.3% | 0.05% | $597K | $45.14 |
| 2024 Q2 | ADDED | 30,971 | +14,482 | +87.8% | 0.08% | $947K | $30.58 |
| 2023 Q3 | ADDED | 16,489 | +11,636 | +239.8% | 0.06% | $370K | $22.41 |
| 2021 Q2 | REDUCED | 4,853 | -1,940 | -28.6% | 0.07% | $205K | $42.27 |
| 2021 Q1 | INITIATED | 6,793 | — | — | 0.16% | $322K | $47.35 |
As of 2025 Q4 — sorted by position size